Inside the US, copyright enterprise?GH Study went general public and presently enjoys a market place capitalisation of around $850 million, while ATAI Existence Sciences, backed by billionaire Peter Thiel and with four drugs in clinical trials on the run,?has fallen from an analogous valuation to about $500 million. Innovation By Mark Whittaker Re